thiothixene

Trade name: navane

Small moleculeapproved

Approved

Jul 24, 1967

THIOTHIXENE, (E)- (trans-thiothixene) )is a clinically inactive isomer of thiothixene. 1000 times higher concentration of this isomer than the active cis-isomer required to inhibit release of (3H) dopamine from rat striatal slices. Trans-thiothixene is about 50 times less potent than cis-thiothixene in inhibiting 3H-haloperidol binding at their binding sites in the rat brain. Cis-isomer of thiothixene is the active antipsychotic drug used in antipsychotic therapy. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 15 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1960s

  1. Jul 24, 1967

    Pfizer — Earliest FDA Approval

  2. Jul 24, 1967

    Pfizer — NDA Organization

1980s

  1. Jun 5, 1987

    Watson Pharmaceuticals — Marketing Organization

  2. Jun 5, 1987

    Heritage Pharma — Marketing Organization

  3. Jun 5, 1987

    Chartwell Pharmaceuticals — Marketing Organization

  4. Jun 22, 1987

    Teva — Marketing Organization

  5. Jun 23, 1987

    Mylan — Marketing Organization

  6. Jun 23, 1987

    Rising Pharmaceuticals — Marketing Organization

  7. Jun 24, 1987

    Epic Pharma Llc — Marketing Organization

  8. Jun 24, 1987

    Sandoz — Marketing Organization

2010s

  1. Apr 5, 2019

    Novitium Pharma — Marketing Organization

2020s

  1. Feb 28, 2022

    Amneal Pharmaceuticals — Marketing Organization

Indications

Mechanism of action

Approval history

  • approvedJul 24, 1967

Chemistry & pharmacology

Loading structure…

SMILES

CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1.Cl.Cl.O.O
Mol. weight
552.59 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Oral, Parenteral
Availability
Discontinued

Oral

Yes

Parenteral

Yes

Topical

No

Black box warning

Sources

Also known as

  • cis-thiothixene
  • cis-thiothixene
  • cis-thiothixene
  • cp-122521
  • cp-122521
  • cp-12252-1
  • cp-12252-1
  • (e)-thiothixene
  • (e)-thiothixene
  • navane
  • navane
  • navane
  • orbinamon
  • orbinamon
  • p-4657b
  • p-4657b
  • thiothixene
  • thiothixene
  • thiothixene
  • thiothixene
  • thiothixene
  • thiothixene
  • thiothixene
  • thiothixene
  • thiothixene
  • thiothixene
  • thiothixene
  • thiothixene hcl
  • thiothixene hcl
  • thiothixene hcl
  • thiothixene hydrochloride
  • thiothixene hydrochloride
  • thiothixene hydrochloride
  • thiothixene hydrochloride
  • thiothixene hydrochloride intensol
  • thiothixene hydrochloride intensol
  • thiothixine
  • thiothixine
  • tiotixene
  • tiotixene
  • tiotixene
  • tiotixene
  • tiotixeno
  • tiotixeno
  • tiotixenum
  • tiotixenum

Organizations

Marketing (18)

OrganizationOrg typeRelationshipDate
AlpharmaFor profitMKTG
Am TherapFor profitMKTG
Amneal PharmaceuticalsFor profitMKTGFeb 28, 2022
Chartwell PharmaceuticalsFor profitMKTGJun 5, 1987
Epic Pharma LlcFor profitMKTGJun 24, 1987
Epic Pharma LlcFor profitSYNJun 24, 1987
Heritage PharmaFor profitSYNJun 5, 1987
Heritage PharmaFor profitMKTGJun 5, 1987
HikmaFor profitMKTG
MylanFor profitMKTGJun 23, 1987
Novitium PharmaFor profitMKTGApr 5, 2019
PacoFor profitMKTG
PfizerFor profitNDAJul 24, 1967
Rising PharmaceuticalsFor profitMKTGJun 23, 1987
SandozFor profitMKTGJun 24, 1987
TevaFor profitMKTGJun 22, 1987
TevaFor profitSYNOct 16, 1987
Watson PharmaceuticalsFor profitMKTGJun 5, 1987